ANALYSIS OF INFECTIONS OF INTEREST IN PATIENTS TREATED WITH TOFACITINIB IN THE ULCERATIVE COLITIS CLINICAL PROGRAMME

Michael Chiorean  ¹     Christina Ha  ²     Alessandro Armuzzi  ³     Nervin Lawendy  ⁴     Rajiv Mundayat  ⁵     Leonardo Salese     John C. Woolcott     Chinyu Su     Iris Dotan  ^6    
1 Swedish Medical Center, Seattle, United States
² Inflammatory Bowel Disease Center, Los Angeles, United States
³ IBD Unit, Rome, Italy
⁴ Pfizer Inc, Collegeville, United States
⁵ Pfizer Inc, New York, United States
⁶ Tel Aviv University, Tel Aviv, Israel

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)